Ergoteles’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15,767
Closed -$1.72M 74
2023
Q2
$1.72M Buy
15,767
+7,391
+88% +$701K 0.08% 312
2023
Q1
$695K Buy
8,376
+5,320
+174% +$501K 0.03% 626
2022
Q4
$314K Sell
3,056
-26,161
-90% -$3.01M 0.01% 893
2022
Q3
$3.1M Buy
29,217
+12,811
+78% +$1.4M 0.11% 190
2022
Q2
$1.8M Buy
16,406
+13,474
+460% +$1.33M 0.05% 342
2022
Q1
$306K Buy
+2,932
New +$304K 0.01% 828
2021
Q3
Sell
-8,000
Closed -$776K 1173
2021
Q2
$776K Buy
+8,000
New +$694K 0.02% 602
2020
Q4
Sell
-4,600
Closed -$269K 655
2020
Q3
$269K Buy
+4,600
New +$242K 0.04% 382

Other funds holding AMN

Ergoteles's AMN Position: Q3 2023 in Review

Ergoteles sold out of AMN Healthcare (AMN) in Q3 2023, closing a stake of 15,767 shares — an estimated $1.72M sold.

Ergoteles first reported a position in AMN in Q3 2020 and held it in 8 quarters. The position peaked at $3.1M in Q3 2022. 389 funds tracked by Wall St. Rank hold AMN as of Q3 2023.

  • Ergoteles reported no remaining AMN Healthcare position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 15,767 AMN Healthcare shares in Q3 2023, an estimated $1.72M.
  • Ergoteles first reported a position in AMN Healthcare in Q3 2020 and held it in 8 quarters.
  • Ergoteles's AMN Healthcare position peaked at $3.1M in Q3 2022.
  • 389 funds tracked by Wall St. Rank held AMN Healthcare as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.